May 7 |
Neumora Therapeutics GAAP EPS of -$0.34
|
May 7 |
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
|
May 6 |
Neumora Therapeutics to Participate in Upcoming Conferences in May
|
Apr 24 |
We're Hopeful That Neumora Therapeutics (NASDAQ:NMRA) Will Use Its Cash Wisely
|
Apr 18 |
Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success
|
Apr 16 |
Neumora (NMRA) Down on FDA Clinical Hold on Neurology Drug
|
Apr 15 |
Why Is Neurology Focused-Neumora Therapeutics Shares Trading Lower On Monday?
|
Apr 15 |
Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug
|
Apr 15 |
Neumora’s schizophrenia drug hit with clinical hold
|
Apr 15 |
Neumora stock slides as FDA puts Phase 1 schizophrenia study on hold
|